Publications by authors named "M Inage"

Article Synopsis
  • - The study focused on identifying risk factors for COVID-19 deterioration in unvaccinated individuals under 65 years old during Japan's fifth wave, as many cases occurred in this demographic.
  • - Researchers analyzed data from 1,675 patients in Fukushima and created predictive scores to estimate deterioration risk using logistic regression, highlighting significant factors like age, body temperature, oxygen saturation, and comorbidities (diabetes, obesity).
  • - The findings indicated that 8.6% of patients experienced deterioration, with predictors including older age, male gender, and various health issues; two risk scores were developed, DOATS and DOAT, to assess patient risk.
View Article and Find Full Text PDF
Article Synopsis
  • Fremanezumab is a monoclonal antibody for treating migraines, and a phase 3 study evaluated the safety of self-injection using an autoinjector.
  • The study involved 71 migraine patients over 8 weeks and focused on the frequency of treatment-emergent adverse events (TEAEs) during self-injection at home versus at a medical site.
  • Results indicated that while at-home injections had more mild injection site reactions, the overall safety profile was reassuring, with significant reductions in migraine days reported.
View Article and Find Full Text PDF

An 88-year-old woman visited our hospital for hemoptysis due to ruptured peripheral pulmonary aneurysm diagnosed by contrast computed tomography (CT) and angiography. Her bleeding was stopped by interventional radiology vascular embolization. She was diagnosed with pulmonary tuberculosis due to a positive acid-fast bacillus (AFB) smear test following admission and the positive polymerase chain reaction for tuberculosis, despite no obvious cavity lesions or scatter shadows on CT.

View Article and Find Full Text PDF